Beta-lactamase repressor blai modulates staphylococcus aureus cathelicidin antimicrobial peptide resistance and virulence

22Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

BlaI is a repressor of BlaZ, the beta-lactamase responsible for penicillin resistance in Staphylococcus aureus. Through screening a transposon library in S. aureus Newman for susceptibility to cathelicidin antimicrobial peptide, we discovered BlaI as a novel cathelicidin resistance factor. Additionally, through integrational mutagenesis in S. aureus Newman and MRSA Sanger 252 strains, we confirmed the role of BlaI in resistance to human and murine cathelidicin and showed that it contributes to virulence in human whole blood and murine infection models. We further demonstrated that BlaI could be a target for innate immunebased antimicrobial therapies; by removing BlaI through subinhibitory concentrations of 6-aminopenicillanic acid, we were able to sensitize S. aureus to LL-37 killing.

Cite

CITATION STYLE

APA

Pence, M. A., Haste, N. M., Meharena, H. S., Olson, J., Gallo, R. L., Nizet, V., & Kristian, S. A. (2015). Beta-lactamase repressor blai modulates staphylococcus aureus cathelicidin antimicrobial peptide resistance and virulence. PLoS ONE, 10(8). https://doi.org/10.1371/journal.pone.0136605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free